International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-2 doi: 10.5281/zenodo.7772197
Original Article
Pattern and clinical outcome of patients admitted in pediatric intensive care unit of a tertiary care Hospital, Dhaka, Bangladesh
 ,
 ,
 ,
Published
March 26, 2023
Abstract
Background: In the developing world, morbidity and mortality in under-five year old children is an important public health problem. Paediatric intensive care unit (PICU) is set aside for managing children with life-threatening illnesses. There is increased survival of critically ill children, with advances in intensive care facilities. Outcome depends on the underlying nature of the disease, associated co-morbidities, clinical condition of the patient at presentation, infrastructure and the quality of care provided in the unit. Objective: To examine pattern and clinical outcome of patients admitted in the pediatric intensive care unit. Methods: This is a prospective observational study conducted in Pediatric Intensive Care Unit (PICU) of-Bangladesh Shishu Hospital and Institute, Dhaka, Bangladesh from January to December 2021. All patients from age of 1 month to 18 years admitted to PICU meeting the inclusion criteria are included in the study. PICU records of all admissions, transfer out, discharges and deaths were used for this study. Data used from the records included age, sex, diagnosis, and outcome of all the patients admitted to PICU. The outcome is classified as transfers to pediatric wards, discharges, patients who left against medical advice (LAMA), and deaths. Results: Total of 431 patients were admitted into PICU. (201) 46.6% were infants, and (230) 53.4% patients aged 1-18 years. Their ages ranged from one month to 18 years, with the mean age being 40.01 ± 45.79 months. There were 264 (61.3%) male and 167 (38.7%) female patients giving an M: F ratio of 1.58:1. The most common cause of admission was respiratory 195 (45.2%), infectious 107 (24.8%), surgical 31 (7.2%), cardiovascular 21 (4.9%), neurological 45 (10.4%), haematological 12(2.8%), renal 04 (0.9%) and others 16 (2.7%). Disorders needing surgical intervention were the commonest condition in children of all age groups. The overall mortality rate was 22.5%. Ninety Seven (22.5%) patients died during the period, consisting of 53 (54.6%) males and 44 (45.4%) females, with their mean age being 53.71 months (range, one month to 18 years). 40 (41.2%) of Respiratory dysfunction, 23 (23.7%) of cardiovascular disorders, 12 (12.4%) of neurological problems, 5 (5.2%) of Haematological disfunction, and 17 (17.5%) patients died in the postoperative period. Conclusions: Diseases including infections were the predominant conditions leading to PICU admissions in our setting. In our PICU, mortality is low. Most of the deaths were serious illnesses with poor prognosis that require adequate medical knowledge, facilities, equipment and infrastructure. This forms a major challenge in Low and Middle Income Countries (LMIC). We advocate a focus on continuous development within the sphere of influence. This highlights the importance of addressing critically ill children and expanding intensive care facilities in the region
Recommended Articles
Loading Image...
Volume-4, Issue-2
Citations
141 Views
299 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved